News Medical on MSN15h
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
Gone, But Not Forgotten: Biologique Lotion P50 1970
One writer mourns the banning of the cult-loved Biologique Recherche P50 1970, often referred to as a "facial in a bottle" ...